|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
|
| ||||||||||||||||
BARBARA DUHL-EMSWILER, PH.D. |
| ||||||||||||||||||
|
| ||||||||||||||||||
Barbara Duhl-Emswiler, Director of bde
BioPharmaceutical Resources, has a Ph.D. in organic
chemistry from Michigan State University and over 19 years
experience in the pharmaceutical, biotech & medical
device industries. Prior to establishing bde
BioPharmaceutical Resources, she held scientific and
managerial positions at Johnson & Johnson, Berlex
Laboratories, ProCyte Corporation, and CDR Therapeutics. |
| ||||||||||||||||||
Consulting projects with bde BioPharmaceutical
Resources have included: |
| ||||||||||||||||||
|
Prepare detailed Scope of Work document for a process development project being outsourced |
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
Chemical Development responsibilities encompassed process
& analytical methods development, and clinical &
commercial manufacturing for drug substances, formulated
drug products & medical devices. For example: |
| ||||||||||||||||||
|
Leading project teams responsible for initiating commercial manufacturing of peptide and polymer-based wound care products |
|
| ||||||||||||||||
|
Cost analysis and planning for manufacturing cost reductions |
|
| ||||||||||||||||
|
Sourcing raw materials and packaging components |
|
| ||||||||||||||||
|
Production planning |
|
| ||||||||||||||||
|
Preparing CMC sections for IND and NDA filings, and relevant sections of 510K applications for medical devices. |
|
| ||||||||||||||||
|
|
| |||||||||||||||||
|
Business development: coordinate advertising, trade show presence, and direct mail campaigns to introduce the services and build client awareness. |
|
| ||||||||||||||||
|
Technical director ñ evaluate projects for technical & economic feasibility, primary liaison with client project managers, plan and coordinate production activities among ProCyte groups |
|
| ||||||||||||||||
As Director of Chemical Development at CDR Therapeutics,
she established the chemical development and peptide
synthesis functions for this new biotechnology company,
including: |
|
| |||||||||||||||||
|
Cost analysis assessment of commercial viability of potential drug substances |
|
| ||||||||||||||||
|
Design, staffing & cost-effectively equipping laboratories for peptide synthesis & analysis |
|
| ||||||||||||||||
|
Identification & evaluation of suppliers for scale-up & production of bulk peptides under cGMP, formulation development, and clinical dosage form manufacturing activities. |
|
| ||||||||||||||||
Barbara has participated for 3 years in a Telementoring for Young Women in Science & Engineering program. This is a pioneering program utilizing the internet to facilitate mentoring discussions, pairing high school girls with women active in science & engineering.
|
|
| |||||||||||||||||
|
| ||||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
| |||||||||||||||||
|
|
|
© copyright 1997 - 1998 bde BioPharmaceutical Resources
Last modified 12/26/98